{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:51:05Z","timestamp":1760575865953,"version":"build-2065373602"},"reference-count":39,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J Biochem &amp;amp; Molecular Tox"],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:sec><jats:label\/><jats:p>Methotrexate is an antineoplastic agent prescribed in various treatment protocols, particularly for psoriasis. Studies on toxicogenomic and clinical data suggest that polymorphism in genes involved in folate metabolism are linked to varying individual responses to methotrexate (MTX). This study aimed to investigate the single nucleotide polymorphisms (SNPs) of two genetic DNA markers (MTHFR 677\u2009C and ABCC2 C), their correlation to protein expression, and laboratory investigations as potential predictors of susceptibility to MTX toxicity among patients. This is a case\u2010control study involving 90 patients treated with methotrexate at the Kasr Al\u2010Ainy psoriasis unit (KAPU), Department of Dermatology. Upon assessing genetic marker polymorphisms, the MTHFR 677\u2009C allele was the most common among all patients (69%). There were more patients with the mutant homozygous (TT) allele in the case group compared to the control group (30% vs. 7%). The ABCC2 C allele was the most prevalent (75%), with the T allele present in 25% of patients. The case group exhibited a lower expression of the CT allele compared to the control group (30% vs. 53%), with a significant difference between the two groups. MTX levels were higher in the case group, while homocysteine levels did not differ significantly between the groups. The C allele of the ABCC2 gene, with a methotrexate cutoff greater than 4.5081\u2009ng\/ml, and the MTHFR T polymorphism are strongly associated with toxicity. The risk of toxicity in individuals receiving methotrexate can be predicted with a threshold value of 4.5081\u2009ng\/ml for methotrexate levels; however, there was no significant variation in homocysteine levels across the groups.<\/jats:p><\/jats:sec>","DOI":"10.1002\/jbt.70537","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T08:54:55Z","timestamp":1758876895000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of Genetic Marker Polymorphisms (MTHFRC677T and ABCC2 C) for Predicting Methotrexate Toxicity in Psoriasis Patients in Egypt: A Case\u2010Control Study"],"prefix":"10.1002","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7794-5243","authenticated-orcid":false,"given":"Asmaa Mohammad Sayed","family":"Ahmed","sequence":"first","affiliation":[{"name":"Department of Forensic Medicine and Clinical Toxicology, Faculty of Medicine Cairo University Cairo Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mervat Hamdy Abdel","family":"Salam","sequence":"additional","affiliation":[{"name":"Department of Forensic Medicine and Clinical Toxicology, Faculty of Medicine Cairo University Cairo Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eman A. F.","family":"Zohairy","sequence":"additional","affiliation":[{"name":"Department of Forensic Medicine and Clinical Toxicology, Faculty of Medicine Cairo University Cairo Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed H. M.","family":"EL\u2010Komy","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Faculty of Medicine Cairo University Cairo Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marwa","family":"Abdelgwad","sequence":"additional","affiliation":[{"name":"Department of Medical Biochemistry and Molecular Biology Cairo University Cairo Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hussein A.","family":"Nasr","sequence":"additional","affiliation":[{"name":"Broomfield Hospital Chelmsford Essex UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abrar Roshdy","family":"Abouelkheir","sequence":"additional","affiliation":[{"name":"Department of Forensic Medicine and Clinical Toxicology, Faculty of Medicine Cairo University Cairo Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2025,9,26]]},"reference":[{"issue":"1","key":"e_1_2_10_2_1","first-page":"1","article-title":"Association of Genetic Polymorphisms on Methotrexate Toxicity in Patients With Rheumatoid Arthritis","volume":"16","author":"Romero M. Z.","year":"2020","journal-title":"Archives of Medical Science"},{"issue":"6","key":"e_1_2_10_3_1","first-page":"800","article-title":"Polymorphisms Within Methotrexate Pathway Genes: Relationship Between Plasma Methotrexate Levels, Toxicity Experienced and Outcome in Pediatric Acute Lymphoblastic Leukemia","volume":"23","author":"Esmaili M. A.","year":"2020","journal-title":"Iranian Journal of Basic Medical Sciences"},{"doi-asserted-by":"publisher","key":"e_1_2_10_4_1","DOI":"10.1038\/s41397-018-0047-z"},{"doi-asserted-by":"publisher","key":"e_1_2_10_5_1","DOI":"10.1038\/s41397-019-0134-9"},{"doi-asserted-by":"publisher","key":"e_1_2_10_6_1","DOI":"10.1016\/j.biopha.2021.111456"},{"doi-asserted-by":"publisher","key":"e_1_2_10_7_1","DOI":"10.3899\/jrheum.091311"},{"doi-asserted-by":"publisher","key":"e_1_2_10_8_1","DOI":"10.3390\/ijms24087329"},{"doi-asserted-by":"publisher","key":"e_1_2_10_9_1","DOI":"10.3389\/fmed.2022.869912"},{"doi-asserted-by":"publisher","key":"e_1_2_10_10_1","DOI":"10.1038\/sj.jid.5700808"},{"doi-asserted-by":"crossref","unstructured":"A.Yahia R.Labib S. A.Abdelshafi et al. \u201cABCC2 (rs717620) and ABCC3 (rs4793665) Affect High Dose Methotrexate Toxicity and Outcome in Children With Osteosarcoma \u201d Authorea Preprints accessed September 22 2025 https:\/\/doi.org\/10.22541\/au.160862664.48679739\/v1.","key":"e_1_2_10_11_1","DOI":"10.22541\/au.160862664.48679739\/v1"},{"doi-asserted-by":"publisher","key":"e_1_2_10_12_1","DOI":"10.1016\/j.pharmthera.2005.06.005"},{"doi-asserted-by":"publisher","key":"e_1_2_10_13_1","DOI":"10.1158\/1078-0432.CCR-08-2940"},{"doi-asserted-by":"publisher","key":"e_1_2_10_14_1","DOI":"10.1093\/toxsci\/kfu162"},{"doi-asserted-by":"publisher","key":"e_1_2_10_15_1","DOI":"10.1016\/j.toxac.2024.10.002"},{"doi-asserted-by":"publisher","key":"e_1_2_10_16_1","DOI":"10.1016\/j.jaad.2024.03.008"},{"doi-asserted-by":"publisher","key":"e_1_2_10_17_1","DOI":"10.1111\/ced.12062"},{"doi-asserted-by":"publisher","key":"e_1_2_10_18_1","DOI":"10.1136\/amiajnl-2014-002642"},{"doi-asserted-by":"publisher","key":"e_1_2_10_19_1","DOI":"10.1371\/journal.pone.0154744"},{"doi-asserted-by":"publisher","key":"e_1_2_10_20_1","DOI":"10.1016\/j.ad.2019.05.009"},{"doi-asserted-by":"publisher","key":"e_1_2_10_21_1","DOI":"10.1186\/s41100-018-0180-9"},{"doi-asserted-by":"publisher","key":"e_1_2_10_22_1","DOI":"10.3352\/jeehp.2021.18.17"},{"doi-asserted-by":"crossref","unstructured":"C.Membrive C. P.Ram\u00edrez N. M.Pete et al. (2020). 5PSQ\u2010065 Prediction of Toxicity of Methotrexate by Means of Genetic Tests in Patients Diagnosed With Moderate\u2013severe Psoriasis.","key":"e_1_2_10_23_1","DOI":"10.1136\/ejhpharm-2020-eahpconf.382"},{"key":"e_1_2_10_24_1","first-page":"391","article-title":"Biostatistics 102: Quantitative Data\u2013Parametric & Non\u2010Parametric Tests","volume":"44","author":"Chan Y. H.","year":"2003","journal-title":"Singapore Medical Journal"},{"doi-asserted-by":"publisher","key":"e_1_2_10_25_1","DOI":"10.1186\/ar419"},{"doi-asserted-by":"publisher","key":"e_1_2_10_26_1","DOI":"10.31557\/APJCP.2024.25.7.2229"},{"doi-asserted-by":"publisher","key":"e_1_2_10_27_1","DOI":"10.1001\/archderm.1972.01620050011002"},{"issue":"7","key":"e_1_2_10_28_1","first-page":"848","article-title":"A Comparison of Psoriasis Drug Failure Rates and Reasons for Discontinuation in Biologics vs Conventional Systemic Therapies","volume":"13","author":"Levin A. A.","year":"2014","journal-title":"Journal of drugs in dermatology: JDD"},{"doi-asserted-by":"publisher","key":"e_1_2_10_29_1","DOI":"10.1111\/bjd.15753"},{"doi-asserted-by":"publisher","key":"e_1_2_10_30_1","DOI":"10.18632\/oncotarget.13876"},{"doi-asserted-by":"publisher","key":"e_1_2_10_31_1","DOI":"10.1080\/17425255.2020.1777279"},{"doi-asserted-by":"publisher","key":"e_1_2_10_32_1","DOI":"10.1016\/j.lfs.2020.118907"},{"doi-asserted-by":"publisher","key":"e_1_2_10_33_1","DOI":"10.1007\/s00431-023-05267-8"},{"doi-asserted-by":"publisher","key":"e_1_2_10_34_1","DOI":"10.3389\/fonc.2021.759805"},{"doi-asserted-by":"publisher","key":"e_1_2_10_35_1","DOI":"10.2217\/pgs-2016-0004"},{"issue":"4","key":"e_1_2_10_36_1","first-page":"51","article-title":"Transporter Gene Polymorphisms and Methotrexate Adverse Events in Arthritis","volume":"40","author":"De Rotte M. C. F. J.","year":"2014","journal-title":"A Toolbox for Personalized Medicine of Methotrexate Therapy in Arthritis"},{"doi-asserted-by":"publisher","key":"e_1_2_10_37_1","DOI":"10.1016\/j.clml.2020.08.020"},{"doi-asserted-by":"publisher","key":"e_1_2_10_38_1","DOI":"10.1002\/pbc.28387"},{"doi-asserted-by":"publisher","key":"e_1_2_10_39_1","DOI":"10.1016\/j.heliyon.2023.e16444"},{"doi-asserted-by":"publisher","key":"e_1_2_10_40_1","DOI":"10.2217\/pgs.14.97"}],"container-title":["Journal of Biochemical and Molecular Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jbt.70537","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T14:44:37Z","timestamp":1760539477000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jbt.70537"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,26]]},"references-count":39,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["10.1002\/jbt.70537"],"URL":"https:\/\/doi.org\/10.1002\/jbt.70537","archive":["Portico"],"relation":{},"ISSN":["1095-6670","1099-0461"],"issn-type":[{"type":"print","value":"1095-6670"},{"type":"electronic","value":"1099-0461"}],"subject":[],"published":{"date-parts":[[2025,9,26]]},"assertion":[{"value":"2024-07-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-15","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-26","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70537"}}